National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 14700 [05-5660]

Download as PDF 14700 Federal Register / Vol. 70, No. 55 / Wednesday, March 23, 2005 / Notices in at the security desk upon entering the building. Information is also available on the Institute’s/Center’s home page: www.nih.gov/ od/oar/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 496–6701. Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Jane Kinsel, Executive Secretary, NACCAM, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–496–6701, Fax 301–480–0087, or via e-mail at naccames@mail.nih.gov. Dated: March 15, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5665 Filed 3–22–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting. This meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussion could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: July 29, 2005. Closed: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: 6707 Democracy Boulevard, Two Democracy, Room 401, Bethesda, Maryland 20892, (Telephone Conference Call). Contact Person: Jane F. Kinsel, PhD, M.B.A., Executive Secretary, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 VerDate jul<14>2003 16:27 Mar 22, 2005 Jkt 205001 Dated: March 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy, NIH. [FR Doc. 05–5668 Filed 3–22–05; 8:45 am] Dated: March 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy, NIH. [FR Doc. 05–5669 Filed 3–22–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting BILLING CODE 4140–01–M National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Meeting Pursuant to Section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: April 4, 2005. Open: 12:30 p.m. to 2:30 p.m. Agenda: The agenda includes Opening Remarks by Director, NCCAM, and a Concept for Milk Thistle RFA. Place: 6707 Democracy Boulevard, Two Democracy, Room 401, Bethesda, Maryland 20892, (Telephone Conference Call). Contact Person: Jane F. Kinsel, Executive Secretary, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 496–6701. The meeting is being published less than 15 days prior to the meeting due to scheduling conflicts. Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Jane Kinsel, Executive Secretary, NACCAM, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–496–6701, Fax 301–480–0087, or via e-mail at naccames@mail.nih.gov. PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Loan Repayment Program (L30 and L40s). Date: April 8, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Jamie Varghese, PhD, Health Science Administrator, DHVD/HRP, NIH/NHLBI, Rockledge 2, Room 9204, 6701 Rockledge Drive, Bethesda, MD 20892–7950, 301–435–0510, varghesej@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Disorders Research; 93.837, Heart and Vascular Disease Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: March 15, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5660 Filed 3–22–05; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 70, Number 55 (Wednesday, March 23, 2005)]
[Notices]
[Page 14700]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5660]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Loan Repayment Program (L30 and L40s).
    Date: April 8, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Jamie Varghese, PhD, Health Science 
Administrator, DHVD/HRP, NIH/NHLBI, Rockledge 2, Room 9204, 6701 
Rockledge Drive, Bethesda, MD 20892-7950, 301-435-0510, 
varghesej@mail.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Disorders Research; 93.837, Heart and Vascular 
Disease Research; 93.838, Lung Diseases Research; 93.839, Blood 
Diseases and Resources Research, National Institutes of Health, HHS)

    Dated: March 15, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-5660 Filed 3-22-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.